Protalix BioTherapeutics Net Income 2006-2021 | PLX
For a detailed definition, formula and example for Net Income, check out our new background page here.
Protalix BioTherapeutics net income from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Protalix BioTherapeutics Annual Net Income
(Millions of US $) |
| 2020 |
$-7 |
| 2019 |
$-18 |
| 2018 |
$-26 |
| 2017 |
$-83 |
| 2016 |
$-29 |
| 2015 |
$58 |
| 2014 |
$-30 |
| 2013 |
$-28 |
| 2012 |
$-12 |
| 2011 |
$-37 |
| 2010 |
$-29 |
| 2009 |
$-31 |
| 2008 |
$-22 |
| 2007 |
$-32 |
| 2006 |
$-9 |
| 2005 |
$-6 |
Protalix BioTherapeutics Quarterly Net Income
(Millions of US $) |
| 2021-06-30 |
$-11 |
| 2021-03-31 |
$-5 |
| 2020-12-31 |
$0 |
| 2020-09-30 |
$-4 |
| 2020-06-30 |
$-4 |
| 2020-03-31 |
$2 |
| 2019-12-31 |
$0 |
| 2019-09-30 |
$-4 |
| 2019-06-30 |
$-8 |
| 2019-03-31 |
$-7 |
| 2018-12-31 |
$-5 |
| 2018-09-30 |
$-5 |
| 2018-06-30 |
$-8 |
| 2018-03-31 |
$-7 |
| 2017-12-31 |
$-13 |
| 2017-09-30 |
$-11 |
| 2017-06-30 |
$0 |
| 2017-03-31 |
$-59 |
| 2016-12-31 |
$-3 |
| 2016-09-30 |
$-7 |
| 2016-06-30 |
$-11 |
| 2016-03-31 |
$-9 |
| 2015-12-31 |
$73 |
| 2015-09-30 |
$-4 |
| 2015-06-30 |
$-5 |
| 2015-03-31 |
$-6 |
| 2014-12-31 |
$-8 |
| 2014-09-30 |
$-8 |
| 2014-06-30 |
$-6 |
| 2014-03-31 |
$-7 |
| 2013-12-31 |
$-11 |
| 2013-09-30 |
$-6 |
| 2013-06-30 |
$-7 |
| 2013-03-31 |
$-4 |
| 2012-12-31 |
$-10 |
| 2012-09-30 |
$-5 |
| 2012-06-30 |
$10 |
| 2012-03-31 |
$-6 |
| 2011-12-31 |
$-9 |
| 2011-09-30 |
$-9 |
| 2011-06-30 |
$-14 |
| 2011-03-31 |
$-5 |
| 2010-12-31 |
$-9 |
| 2010-09-30 |
$-2 |
| 2010-06-30 |
$-10 |
| 2010-03-31 |
$-8 |
| 2009-12-31 |
$-15 |
| 2009-09-30 |
$-6 |
| 2009-06-30 |
$-5 |
| 2009-03-31 |
$-5 |
| 2008-12-31 |
$-7 |
| 2008-09-30 |
$-6 |
| 2008-06-30 |
$-4 |
| 2008-03-31 |
$-5 |
| 2007-12-31 |
$-15 |
| 2007-09-30 |
$-5 |
| 2007-06-30 |
$-9 |
| 2007-03-31 |
$-3 |
| 2006-12-31 |
$-3 |
| 2006-09-30 |
$-2 |
| 2006-06-30 |
$-2 |
| 2006-03-31 |
$-2 |
| 2005-12-31 |
$-6 |
| 2005-09-30 |
$-0 |
| 2005-06-30 |
$-0 |
| 2005-03-31 |
$-0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.053B |
$0.063B |
|
Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.
|
